WuXi’s STA Pharmaceutical recently hosted a knowledge sharing and networking symposium, “Biotech CMC Outsourcing Strategies – Boston.” More than 100 industry CMC professionals and collaborators participated in this event, which focused on perspectives and best practices for successful CMC outsourcing and global regulatory strategies. Attendees heard insights from leaders of some of the most prominent biotech companies in greater Boston area, which is a hotbed on innovation, with new therapies being developed at record speed.

CMC and supply chain management leaders from Vertex, Tesaro and Agios shared their successful stories about how their organizations have managed to meet aggressive drug development timelines while building a sophisticated CMC organization and setting up a robust 100%-outsourced global manufacturing and distribution network.  To adapt to the rapidly changing global regulatory environment, speakers from Syner-G Pharma CMC Consulting and Corbus Pharmaceuticals addressed how to ensure global CMC quality and regulatory compliance as well as strategies for successfully defending regulatory starting material worldwide. We also heard the story about Tesaro’s approach to access the Chinese market, the second largest pharmaceutical market in the world. Our outreach partners for this event include Massachusetts Life Science Center and Massachusetts Biotech Council.

To view the event highlights video, click here.